Physician profile
Deanne Long
NPI 1023087343
$1,504.09
in general payments reported to CMS, 2019-2025
8 companies · $191 in 2025
The $191 reported for 2025 was more than what 82% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $250 · 2021: $345 · 2022: $342 · 2023: $86.79 · 2024: $158 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $776.93 | 2019-2022 | |
| Revance Therapeutics, INC. | $185.32 | 2024-2025 | Daxxify |
| Allergan, INC. | $171.95 | 2019-2022 | |
| Galderma Laboratories, L.P. | $137.99 | 2019-2024 | |
| Abbvie INC. | $114.05 | 2023-2024 | |
| Corcept Therapeutics | $65.14 | 2025 | Korlym |
| Solventum Corporation | $26.57 | 2025 | Activ.A.C., Promogran Prisma |
| Novo Nordisk INC | $26.14 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanne Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.